Department of Psychiatry, NIAAA Center for the Translational Neuroscience of Alcoholism, Yale University School of Medicine, New Haven, CT 06511, USA.
Neuropsychopharmacology. 2011 Feb;36(3):701-10. doi: 10.1038/npp.2010.203. Epub 2010 Dec 1.
Reduced responses to N-methyl-D-aspartate (NMDA) glutamate receptor antagonists in alcohol-dependent animals and humans provided evidence that chronic alcohol consumption increased NMDA receptor function. To further probe alterations in NMDA glutamate receptor function associated with human alcohol dependence, this study examined the interactive effects of agents acting at the glycine(B) coagonist site of the NMDA receptor. In doing so, it tested the hypothesis that raising brain glycine concentrations would accentuate the antagonist-like effects of the glycine(B) partial agonist, D-cycloserine (DCS). Twenty-two alcohol-dependent men and 22 healthy individuals completed 4 test days, during which glycine 0.3 g/kg or saline were administered intravenously and DCS 1000 mg or placebo were administered orally. The study was conducted under double-blind conditions with randomized test day assignment. In this study, DCS produced alcohol-like effects in healthy subjects that were deemed similar to a single standard alcohol drink. The alcohol-like effects of DCS were blunted in alcohol-dependent patients, providing additional evidence of increased NMDA receptor function in this group. Although glycine administration reduced DCS plasma levels, glycine accentuated DCS effects previously associated with the NMDA receptor antagonists, ketamine and ethanol. Thus, this study provided evidence that raising glycine levels accentuated the NMDA receptor antagonist-like effects of DCS and that alcohol-dependent patients showed tolerance to these DCS effects.
减少 N-甲基-D-天冬氨酸(NMDA)谷氨酸受体拮抗剂在酒精依赖动物和人类中的反应,提供了证据表明慢性酒精消费增加了 NMDA 受体功能。为了进一步探究与人类酒精依赖相关的 NMDA 谷氨酸受体功能的改变,本研究检查了作用于 NMDA 受体甘氨酸(B)协同位点的药物的相互作用。这样做,它检验了这样一种假设,即提高脑甘氨酸浓度会增强甘氨酸(B)部分激动剂 D-环丝氨酸(DCS)的拮抗剂样作用。22 名酒精依赖男性和 22 名健康个体完成了 4 天的测试,在此期间静脉内给予甘氨酸 0.3g/kg 或生理盐水,口服给予 DCS 1000mg 或安慰剂。该研究在双盲条件下进行,随机分配测试日。在这项研究中,DCS 在健康受试者中产生了类似酒精的作用,被认为类似于单标准酒精饮料。DCS 的酒精样作用在酒精依赖患者中减弱,为该组 NMDA 受体功能增加提供了额外的证据。尽管甘氨酸给药降低了 DCS 的血浆水平,但甘氨酸增强了先前与 NMDA 受体拮抗剂,氯胺酮和乙醇相关的 DCS 效应。因此,本研究提供了证据,表明提高甘氨酸水平会增强 DCS 的 NMDA 受体拮抗剂样作用,并且酒精依赖患者对这些 DCS 作用产生了耐受性。